To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions

Seizure

Interventions

DRUG

Levetiracetam Tablets, 750 mg (Sandoz Inc.)

DRUG

Keppra (Levetiracetam) Tablets, 750 mg (UCB Pharma, Inc)